PLEASANTON, CA--(Marketwired - Oct 21, 2015) - ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced the location and agenda for its 2015 investor and analyst day. The event will be held on November 17, 2015 from 9:30 a.m. ET to 12:00 p.m. ET at the Park Hyatt New York in New York City.

The event will focus on the Company's growth initiatives, R&D pipeline, and financial outlook. It will also include an interactive physician panel that will provide more insight into the Company's recently launched CoolMini™ applicator, new product growth opportunities, and its proprietary cooling technology for the potential therapeutic treatment of acne.

INVESTOR DAY:

Event: ZELTIQ Investor Day
Date: November 17, 2015
Time: 9:30 a.m. ET to 12:00 p.m. ET (Registration begins at 9:00 a.m. ET)
Location: Park Hyatt New York - ONYX Room (153 W 57th Street)

The agenda will include:

  • Executive management presentations on new market opportunities from products such as CoolSmooth PRO™ and CoolMini applicators, as well as the Company's R&D pipeline, Direct-to-Consumer strategy, and long term financial profile
  • Physician presentations on the CoolMini applicator and clinical data on the potential treatment of acne through the company's proprietary cooling technology
  • Q&A with Executive Management
  • Interactive Physician Panel with Audience Q&A

ZELTIQ is honored to welcome the following physicians as participants for the event:

  • Richard Rox Anderson, M.D., A.B.D., -- Massachusetts General Hospital, Boston, MA
  • Farid Kazem, M.D., A.S.P.S., I.S.A.P.S. -- Kazem Aesthetics, Leimuiden, Netherlands
  • Grant Stevens, M.D., F.A.C.S. -- Marina Plastic Surgery, Los Angeles, CA

Please RSVP to RSVP@zeltiq.com by November 16, 2015.

INVESTOR CONFERENCES:

Mark Foley, President and Chief Executive Officer, and Patrick F. Williams, Senior Vice President and Chief Financial Officer, are scheduled to participate in three investor conferences in November 2015.

Event: Stifel 2015 Healthcare Conference
Format: Presentation and One-on-One Meetings
Date: Wednesday, November 18, 2015
Where: New York Palace Hotel, New York, NY
Time: 9:30 a.m. ET / 6:30 a.m. PT

Event: Goldman Sachs US Emerging & SMID Cap Growth Conference
Format: Presentation and One-on-One Meetings
Date: Thursday, November 19, 2015
Where: Crown Plaza Times Square, New York, NY
Time: 10:10 a.m. ET / 7:10 a.m. PT

Event: Canaccord Genuity Medical Technology and Diagnostics Forum
Format: Presentation and One-on-One Meetings
Date: Thursday, November 19, 2015
Where: Westin New York Grand Central, New York, NY
Time: 10:30 a.m. ET / 7:30 a.m. PT

Audio webcasts of the Company's presentations will be available by visiting the investor relations section of ZELTIQ's web site at www.coolsculpting.com. Replays of the presentations will be available for 90 days.

About ZELTIQ® Aesthetics
ZELTIQ is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting® System, is designed to selectively reduce stubborn fat bulges. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed CoolSculpting to safely, noticeably, and measurably reduce the fat layer.